About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Drugs by Therapeutic Area
Insomnia Market Expected to Grow at 6.1% by 2032
Insomnia Market By Treatment Type, By Sales Channel, By Region - Global Market Analysis & Forecast, 2024 to 2032
07 Nov 2024
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Insomnia Market
2.2. Global Insomnia Market, By , 2023 (US$ Million)
2.3. Global Insomnia Market, By Treatment Type, 2023 (US$ Million)
2.4. Global Insomnia Market, By Sales Channel, 2023 (US$ Million)
2.5. Global Insomnia Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023
3. Insomnia Market: Competitive Analysis
3.1. Market Positioning of Key Insomnia Market Vendors
3.2. Strategies Adopted by Insomnia Market Vendors
3.3. Key Industry Strategies
4. Insomnia Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Insomnia Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Insomnia Market: By , 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
6. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Benzodiazepines
6.3.2. Nonbenzodiazepines
6.3.3. Antidepressants
6.3.4. Orexin Antagonist
6.3.5. Melatonin Antagonist
6.3.6. Devices
6.3.7. Others
7. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies and Drug Stores
7.3.3. Online Pharmacies
8. North America Insomnia Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Insomnia Market: By , 2022-2032, USD (Million)
8.3. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
8.4. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
8.5.Insomnia Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Insomnia Market: By , 2022-2032, USD (Million)
8.5.1.1.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
8.5.1.1.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Insomnia Market: By , 2022-2032, USD (Million)
8.5.1.2.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
8.5.1.2.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Insomnia Market: By , 2022-2032, USD (Million)
8.5.1.3.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
8.5.1.3.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9. UK and European Union Insomnia Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Insomnia Market: By , 2022-2032, USD (Million)
9.3. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.4. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.Insomnia Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.1.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.1.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.2.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.2.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.3.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.3.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.4.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.4.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.5.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.5.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Insomnia Market: By , 2022-2032, USD (Million)
9.5.1.6.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
9.5.1.6.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10. Asia Pacific Insomnia Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Insomnia Market: By , 2022-2032, USD (Million)
10.3. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.4. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.Insomnia Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.1.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.1.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.2.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.2.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.3.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.3.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.4.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.4.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.5.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.5.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Insomnia Market: By , 2022-2032, USD (Million)
10.5.1.6.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
10.5.1.6.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
11. Latin America Insomnia Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Insomnia Market: By , 2022-2032, USD (Million)
11.3. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
11.4. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
11.5.Insomnia Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Insomnia Market: By , 2022-2032, USD (Million)
11.5.1.1.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
11.5.1.1.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Insomnia Market: By , 2022-2032, USD (Million)
11.5.1.2.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
11.5.1.2.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Insomnia Market: By , 2022-2032, USD (Million)
11.5.1.3.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
11.5.1.3.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
12. Middle East and Africa Insomnia Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Insomnia Market: By , 2022-2032, USD (Million)
12.3. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
12.4. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
12.5.Insomnia Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Insomnia Market: By , 2022-2032, USD (Million)
12.5.1.1.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
12.5.1.1.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Insomnia Market: By , 2022-2032, USD (Million)
12.5.1.2.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
12.5.1.2.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Insomnia Market: By , 2022-2032, USD (Million)
12.5.1.3.2. Insomnia Market: By Treatment Type, 2022-2032, USD (Million)
12.5.1.3.3. Insomnia Market: By Sales Channel, 2022-2032, USD (Million)
13. Company Profile
13.1. Paratek Pharmaceuticals, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Sumitomo Dainippon Pharma Co., Ltd.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Teva Pharmaceutical Industries Limited
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Vanda Pharmaceuticals Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Takeda Pharmaceutical Company Limited
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Pfizer Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Sanofi S.A
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Merck & Co., Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Viatris Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Other Notable Players
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4500
Multi User license
$6500
Corporate license
$13000
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234